Research

The clinical trial of the HIPRA vaccine against COVID-19 is progressing with the administration of the first doses to humans

This week the vaccine began to be administered to the first volunteers participating in Phase I/IIa of the trial at the Hospital Trueta in Girona and the Hospital Universitari Clínic in Barcelona. 

The first people to take part in Phase I/IIa of the HIPRA COVID-19 vaccine clinical trial received the first dose this week.

Related contents